Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

colloidal bismuth pectin granules

A granule-based formulation containing colloidal bismuth pectin (CBP), with potential cytoprotective activities. Upon oral administration of the colloidal bismuth, bismuth inhibits peptic activity, increases mucosal secretions of prostaglandins and bicarbonate and acts as a barrier to prevent damage by acids. It also prevents adhesion of Helicobacter (H.) pylori to epithelial cells and can inhibit enzymes secreted by H. pylori. This protects against ulcer formation and may help heal existing ulcers.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	bismuth colloidal pectin granules CBP granules

colloidal bismuth pectin granules

Search NCI's Drug Dictionary